MarketingRx Matchup: Is it Novo Nordisk’s Ozempic or Lilly and BI’s Jardiance for the win in Type 2 ads?
While it’s not quite time for March Madness yet, we’re warming up this week with some MarketingRx’s advertising madness.
This month’s DTC matchup gauges consumers’ opinions of two Type 2 diabetes TV ads — one from Novo Nordisk’s Ozempic and the other from Eli Lilly and Boehringer Ingelheim’s co-marketed Jardiance.
Both the Ozempic ad and the Jardiance ad began running in January, although both are also part of long-running campaigns. The Ozempic campaign with its hallmark “Oh Oh Oh Ozempic” jingle initially launched in 2018, while Jardiance’s “On It” theme began in 2019.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
